Medical Device News Magazine

ZAP Surgical Systems Announces Chairman of Foxconn Technology Joins Board of Directors

Appointment Demonstrates Foxconn and ZAP Co-Founder Terry Guo’s Commitment to Accelerated Commercialization of ZAP-X Non-Invasive Brain Tumor Treatment Platform

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

ZAP Surgical Systems, Inc., developer and manufacturer of the ZAP-X® surgical robot for non-invasive ablation of brain tumors, today announced that the Chairman of Foxconn Technology Co Ltd, Lu Jun-Fu (Stanley Lu), has joined the ZAP Surgical Board of Directors.

“I am thrilled to welcome Stanley Lu to our Board of Directors where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said Dr. John R. Adler, MD, Stanford Professor of Neurosurgery and founder & Chief Executive Officer of ZAP Surgical Systems. “At ZAP we have developed the next-generation platform for non-invasively treating brain cancer. Unfortunately, more than 4 million people each year suffer from brain, head & neck cancers and are not being treated optimally with existing radiosurgical solutions. ZAP’s singular goal is to meet this challenge.”

Stanley Lu is the Chairman of Foxconn Technology Co Ltd, elected in October 2021. Stanley received an EMBA from the Chinese University of Hong Kong and an EMBA from the National Sun Yat-sen University. Prior, Stanley was the Chief Financial Officer and spokesperson of Foxsemicon Integrated Technology Inc.

Terry Guo, founder and former Chairman and Chief Executive Officer of Foxconn, co-founded ZAP Surgical in 2014, and contributed entrepreneurial expertise and his anchor investment established ZAP Surgical as an independent company. Prior to the company’s inception, the ZAP-X platform was developed within and spun out from Varian Medical Systems, now a Siemens Healthineers company.

In addition to Foxconn and Siemens Healthineers, ZAP investors include Primavera Capital Group, Chow Tai Fook Enterprises, GT Healthcare Capital Partners, ShangBay Capital, and Hogy Medical.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.